Rivermark Medical Funding & Investors
Milwaukee, WI
Rivermark Medical develops a minimally-invasive treatment for Benign Prostatic Hyperplasia (BPH) that restores urinary function. Developed by urologists to reliably reduce BPH symptoms with minimal side effects.
rivermarkmedical.comTotal Amount Raised: $34,700,000
Rivermark Medical Funding Rounds
Series C
$30,000,000
Series C Investors
American CenturyTIME BioVenturesVenture InvestorsCadence Healthcare VenturesAnduril InvestorsView VenturesSeries B
$2,149,999
Series B Investors
Anduril InvestorsView VenturesCadence Healthcare VenturesSeries A
$2,550,000
Funding info provided by Diffbot.